|Study Description:||The goal of this clinical research study is to compare the effectiveness of the |
combination of gemcitabine and pazopanib to gemcitabine alone in patients with
ovarian cancer, Fallopian tube cancer, or primary peritoneal cancer.
Researchers also want to learn about the possible side effects and safety of
the study drug combination.
Gemcitabine is designed to block the growth of cancer cells, which may cause
them to die.
Pazopanib is designed to block the growth of blood vessels that supply
nutrients needed for tumor growth. This may prevent or slow the growth of